ArticleOncotarget2016

ctDNA dynamics: a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapy.

Fei Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.